Atlas Trials

Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma

Clinical trial NCT06587802 · RECRUITING

Trial details

NCT number
NCT06587802
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Adrenocortical Carcinoma
Start date
2025-03-14
Primary completion
2027-03-14
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.